Today: 20 May 2026
Browse Category

LSE:NXT 6 January 2026 - 6 February 2026

UK Stock Market Forecast 2026: FTSE 100 clings to rate-cut bets as AI jitters hit data stocks

UK Stock Market Forecast 2026: FTSE 100 clings to rate-cut bets as AI jitters hit data stocks

London’s FTSE 100 rose 0.2% by midday Friday, led by gains in Barclays, NatWest, and Lloyds, while RELX dropped 3.5% amid an AI selloff. The Bank of England held rates at 3.75% after a narrow vote and signaled possible cuts if inflation slows. Sterling fell 0.6% against the dollar. Markets now expect the Bank Rate to fall to 3.0% by March 2027.
Next buys Russell & Bromley for £3.8m — and leaves 33 stores facing an uncertain future

Next buys Russell & Bromley for £3.8m — and leaves 33 stores facing an uncertain future

Next is acquiring Russell & Bromley’s brand and intellectual property for £2.5 million and some stock for £1.3 million, with court approval expected later Wednesday. The deal includes three stores; 33 stores and nine concessions remain in administration and will keep trading as options are reviewed. Retail Realisation is handling stock clearance for excluded outlets. Next shares fell 0.3% in London morning trading.
21 January 2026
UK stock market today: FTSE 100 hits fresh high as Next upgrade lifts retailers and oil majors rise

UK stock market today: FTSE 100 hits fresh high as Next upgrade lifts retailers and oil majors rise

FTSE 100 rose 0.6% to 10,061 in early London trade, near record highs after Next lifted its profit outlook and energy stocks advanced. Next shares gained 3.1% as full-price sales jumped 10.6%. Tesco and Sainsbury’s also climbed after new grocery data showed rising sales and easing inflation. BP and Shell advanced, while JD Sports fell 6.4%.

Stock Market Today

  • Stock Market Continues Modest Pullback as Leading Growth Stocks Hold
    May 19, 2026, 7:45 PM EDT. The stock market extended its losing streak to three sessions on Tuesday, marking a modest and orderly pullback. Despite the slump, leading growth stocks demonstrated resilience, showing signs of underlying strength amid broader market pressure. Investors are watching carefully as the overall market digests recent gains, while specific oil and gas companies attract attention for potential opportunities. This cautious environment suggests investors are balancing profit-taking with selective buying in sectors showing robust performance.

Latest articles

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

20 May 2026
GCL Global Holdings shares jumped to $1.00 after hours Tuesday, up 132%, following news that ADATA Technology invested another $10 million in its 4Divinity unit. The stock had closed regular trading at $0.43, below Nasdaq’s $1 minimum. Recent filings still warn of listing and execution risks. GCL reported first-half revenue up 94% to $98.7 million but posted a net loss of $5.6 million.
James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Go toTop